Inflammatory mediators in chronic heart failure: an overview

Heart. 2004 Apr;90(4):464-70. doi: 10.1136/hrt.2002.007005.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • C-Reactive Protein / metabolism
  • Cell Adhesion Molecules / physiology
  • Cytokines / physiology
  • Etanercept
  • Heart Failure / drug therapy
  • Heart Failure / immunology*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Immunoglobulin G / therapeutic use
  • Infliximab
  • Leukocytes / immunology
  • Lymphocyte Subsets
  • Myocarditis / immunology
  • Nitric Oxide / physiology
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • Cell Adhesion Molecules
  • Cytokines
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Nitric Oxide
  • C-Reactive Protein
  • Infliximab
  • Etanercept